data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Phathom Pharmaceuticals
(NASDAQ:PHAT)
$8.59
0.15[1.78%]
Last update: 10:36AM
15 minutes delayed
Day High/Low8.07 - 8.69
52 Week High/Low6.1 - 37.17
Open / Close8.41 / -
Float / Outstanding24.3M / 39.1M
Vol / Avg.9.6K / 276.7K
Mkt Cap335.6M
P/E-
50d Avg. Price9.08
Div / Yield-
Payout Ratio-
EPS-1.07
Total Float24.3M

Phathom Pharmaceuticals (NASDAQ:PHAT), Quotes and News Summary

Phathom Pharmaceuticals (NASDAQ: PHAT)

Day High/Low8.07 - 8.69
52 Week High/Low6.1 - 37.17
Open / Close8.41 / -
Float / Outstanding24.3M / 39.1M
Vol / Avg.9.6K / 276.7K
Mkt Cap335.6M
P/E-
50d Avg. Price9.08
Div / Yield-
Payout Ratio-
EPS-1.07
Total Float24.3M
Benzinga - Jun 22, 2022, 4:49AM
Benzinga - May 25, 2022, 3:02PM
Benzinga - May 25, 2022, 8:01AM
Benzinga - May 24, 2022, 10:17AM
Benzinga - May 10, 2022, 12:38PM
Benzinga - May 10, 2022, 8:16AM
Benzinga - May 6, 2022, 10:08AM
Benzinga - May 4, 2022, 8:02AM
Benzinga - Apr 13, 2022, 2:10PM
Benzinga - Mar 22, 2022, 8:08AM
Benzinga - Mar 14, 2022, 8:06AM
Benzinga - Mar 1, 2022, 4:21PM
Benzinga - Feb 10, 2022, 10:02AM
Benzinga - Feb 9, 2022, 4:29PM
Benzinga - Feb 9, 2022, 4:05PM
Benzinga - Nov 8, 2021, 8:20AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-09
REV
Q1 2022Est.ActualSurprise
EPS-0.970-1.070 -0.1000
REV210.000K0-210.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Phathom Pharmaceuticals Questions & Answers

Q
How do I buy Phathom Pharmaceuticals (PHAT) stock?
A

You can purchase shares of Phathom Pharmaceuticals (NASDAQ: PHAT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Phathom Pharmaceuticals's (PHAT) competitors?
Q
What is the target price for Phathom Pharmaceuticals (PHAT) stock?
A

The latest price target for Phathom Pharmaceuticals (NASDAQ: PHAT) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting PHAT to rise to within 12 months (a possible 74.62% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Phathom Pharmaceuticals (PHAT)?
A

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $8.59 last updated Today at July 1, 2022, 2:36 PM UTC.

Q
Does Phathom Pharmaceuticals (PHAT) pay a dividend?
A

There are no upcoming dividends for Phathom Pharmaceuticals.

Q
When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?
A

Phathom Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 9, 2022.

Q
Is Phathom Pharmaceuticals (PHAT) going to split?
A

There is no upcoming split for Phathom Pharmaceuticals.

Q
What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?
A

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.